Cargando…

Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1

OBJECTIVE(S): Fumonisins are a group of toxic and carcinogenic mycotoxins, which contaminate the grains and their products. The aim of this study was to examine the apoptotic and proliferative activity of mouse gastric mucosa following administration of fumonisin B1 (FB1). MATERIALS AND METHODS: Twe...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Ali Mohammad, Mohammadghasemi, Fahimeh, Zendehdel, Kazem, Kamyabi-moghaddam, Zahra, Tavassoli, Abbas, Amini-najafi, Fatemeh, Khosravi, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366747/
https://www.ncbi.nlm.nih.gov/pubmed/25810870
_version_ 1782362414563459072
author Alizadeh, Ali Mohammad
Mohammadghasemi, Fahimeh
Zendehdel, Kazem
Kamyabi-moghaddam, Zahra
Tavassoli, Abbas
Amini-najafi, Fatemeh
Khosravi, Alireza
author_facet Alizadeh, Ali Mohammad
Mohammadghasemi, Fahimeh
Zendehdel, Kazem
Kamyabi-moghaddam, Zahra
Tavassoli, Abbas
Amini-najafi, Fatemeh
Khosravi, Alireza
author_sort Alizadeh, Ali Mohammad
collection PubMed
description OBJECTIVE(S): Fumonisins are a group of toxic and carcinogenic mycotoxins, which contaminate the grains and their products. The aim of this study was to examine the apoptotic and proliferative activity of mouse gastric mucosa following administration of fumonisin B1 (FB1). MATERIALS AND METHODS: Twenty-nine female mice divided into treatment (n=15) and control (n=14) groups. The treatment group received FB1 (150 mg/kg diet) for 16 weeks. The gastric atrophy was allocated using grading criteria modeled on the updated Sydney System. Immunohistochemistry studies were performed for evaluation of apoptosis and proliferative activity in gastric mucosa. RESULTS: Mild to moderate gastric atrophy were observed in microscopic findings of the gastric mucosa in treated animals (P<0.05). Number of parietal cells significantly decreased in the treatment group in comparison with the control (P<0.05). Treatment with FB1 for 16 weeks significantly reduced both gastric mucosa height and mitotic index in the gastric glands (P<0.05). TUNEL- and Bax-labeled positive cell numbers significantly increased in the FB1-treated group compared to the control (P<0.05). In addition, proliferative activity of gastric glands in the treated group was significantly lower than the control (P<0.05). CONCLUSION: Oral administration of FB1 caused atrophy in gastric mucosa both via increasing of apoptosis and suppressing the mitotic activity of these cells.
format Online
Article
Text
id pubmed-4366747
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-43667472015-03-25 Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1 Alizadeh, Ali Mohammad Mohammadghasemi, Fahimeh Zendehdel, Kazem Kamyabi-moghaddam, Zahra Tavassoli, Abbas Amini-najafi, Fatemeh Khosravi, Alireza Iran J Basic Med Sci Original Article OBJECTIVE(S): Fumonisins are a group of toxic and carcinogenic mycotoxins, which contaminate the grains and their products. The aim of this study was to examine the apoptotic and proliferative activity of mouse gastric mucosa following administration of fumonisin B1 (FB1). MATERIALS AND METHODS: Twenty-nine female mice divided into treatment (n=15) and control (n=14) groups. The treatment group received FB1 (150 mg/kg diet) for 16 weeks. The gastric atrophy was allocated using grading criteria modeled on the updated Sydney System. Immunohistochemistry studies were performed for evaluation of apoptosis and proliferative activity in gastric mucosa. RESULTS: Mild to moderate gastric atrophy were observed in microscopic findings of the gastric mucosa in treated animals (P<0.05). Number of parietal cells significantly decreased in the treatment group in comparison with the control (P<0.05). Treatment with FB1 for 16 weeks significantly reduced both gastric mucosa height and mitotic index in the gastric glands (P<0.05). TUNEL- and Bax-labeled positive cell numbers significantly increased in the FB1-treated group compared to the control (P<0.05). In addition, proliferative activity of gastric glands in the treated group was significantly lower than the control (P<0.05). CONCLUSION: Oral administration of FB1 caused atrophy in gastric mucosa both via increasing of apoptosis and suppressing the mitotic activity of these cells. Mashhad University of Medical Sciences 2015-01 /pmc/articles/PMC4366747/ /pubmed/25810870 Text en Copyright: © Iranian Journal of Basic Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Alizadeh, Ali Mohammad
Mohammadghasemi, Fahimeh
Zendehdel, Kazem
Kamyabi-moghaddam, Zahra
Tavassoli, Abbas
Amini-najafi, Fatemeh
Khosravi, Alireza
Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1
title Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1
title_full Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1
title_fullStr Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1
title_full_unstemmed Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1
title_short Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1
title_sort apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin b1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366747/
https://www.ncbi.nlm.nih.gov/pubmed/25810870
work_keys_str_mv AT alizadehalimohammad apoptoticandproliferativeactivityofmousegastricmucosafollowingoraladministrationoffumonisinb1
AT mohammadghasemifahimeh apoptoticandproliferativeactivityofmousegastricmucosafollowingoraladministrationoffumonisinb1
AT zendehdelkazem apoptoticandproliferativeactivityofmousegastricmucosafollowingoraladministrationoffumonisinb1
AT kamyabimoghaddamzahra apoptoticandproliferativeactivityofmousegastricmucosafollowingoraladministrationoffumonisinb1
AT tavassoliabbas apoptoticandproliferativeactivityofmousegastricmucosafollowingoraladministrationoffumonisinb1
AT amininajafifatemeh apoptoticandproliferativeactivityofmousegastricmucosafollowingoraladministrationoffumonisinb1
AT khosravialireza apoptoticandproliferativeactivityofmousegastricmucosafollowingoraladministrationoffumonisinb1